Suppr超能文献

通过实体瘤标本、含肿瘤的腹腔渗出细胞、肿瘤浸润淋巴细胞(TIL)衍生的T细胞系和已建立的肿瘤细胞系,检测人上皮性卵巢癌中细胞因子转录本的差异表达。

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.

作者信息

Nash M A, Lenzi R, Edwards C L, Kavanagh J J, Kudelka A P, Verschraegen C F, Platsoucas C D, Freedman R S

机构信息

Department of Gynecological Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Clin Exp Immunol. 1998 May;112(2):172-80. doi: 10.1046/j.1365-2249.1998.00576.x.

Abstract

T cell lines derived in low concentrations of recombinant IL-2 (rIL-2) from TIL of patients with epithelial ovarian carcinoma (EOC) often exhibit specific cytotoxicity against autologous tumour cells. However, the ability of T cells at the tumour site to respond to ovarian carcinoma cells may be affected by the production of cytokines by the various cell types present. Using reverse transcriptase-polymerase chain reaction (RT-PCR) we investigated cytokine transcripts in: (i) established EOC tumour cell lines; (ii) solid tumour specimens or peritoneal exudate cells (PEC) from ascites or peritoneal washings of patients with EOC; and (iii) CD4+ TCRalphabeta+ and CD8+ TCRalphabeta+ TIL-derived T cell lines developed in rIL-2. We have found that (i) established EOC tumour cell lines expressed transcripts for transforming growth factor-beta 2 (TGF-beta2) (7/7), but not IL-10 (0/7) or interferon-gamma (IFN-gamma) (0/7) and rarely IL-2 (1/7); (ii) PEC expressed transcripts for IL-2 (12/13), IL-10 (9/13), and TGF-beta2 (12/13), and less often, IFN-gamma (3/13), whereas solid tumour specimens from eight patients with EOC expressed transcripts for IL-2 (4/8), TGF-beta2 (4/8), and IL-10 (5/8), but not for IFN-gamma (0/8); (iii) CD4+ TCRalphabeta+ T cell lines expressed transcripts for IFN-gamma (4/4), IL-2 (4/4) and IL-10 (3/4), whereas CD8+ TCRalphabeta+ T cell lines expressed transcripts for IFN-gamma (5/5), IL-2 (1/5) and IL-10 (2/5). None of these T cell lines expressed TGF-beta2 transcripts. The frequency of IL-2 and TGF-beta2 transcripts in solid tumours was significantly lower than in the PEC (P = 0.0475). CD4+ or CD8+ T cell lines expressing IFN-gamma, IL-2 and IL-10 transcripts were derived in culture with rIL-2 from the TIL of specimens that did not necessarily express these cytokines in the absence of rIL-2. The frequency of cytokine transcripts in T cell lines compared with these same transcripts in the PEC was significantly higher for IFN-gamma (P = 0.0005) and lower for TGF-beta2 (P = 0.0001). An association was observed between the expression of cytokine transcripts in vivo or by TIL-derived cell lines and functions exhibited by either production of cytokines or in vitro cytotoxicity.

摘要

从上皮性卵巢癌(EOC)患者的肿瘤浸润淋巴细胞(TIL)中,在低浓度重组白细胞介素-2(rIL-2)条件下衍生出的T细胞系,常常表现出针对自体肿瘤细胞的特异性细胞毒性。然而,肿瘤部位的T细胞对卵巢癌细胞作出反应的能力,可能会受到存在的各种细胞类型所产生的细胞因子的影响。我们使用逆转录聚合酶链反应(RT-PCR),研究了以下样本中的细胞因子转录本:(i)已建立的EOC肿瘤细胞系;(ii)EOC患者腹水或腹腔灌洗的实体瘤标本或腹腔渗出细胞(PEC);以及(iii)在rIL-2中培养出的CD4+ TCRαβ+和CD8+ TCRαβ+ TIL衍生的T细胞系。我们发现:(i)已建立的EOC肿瘤细胞系表达转化生长因子-β2(TGF-β​​2)的转录本(7/7),但不表达白细胞介素-10(IL-10)(0/7)或干扰素-γ(IFN-γ)(0/7),很少表达IL-2(1/7);(ii)PEC表达IL-2(12/13)、IL-10(9/13)和TGF-β​​2(12/13)的转录本,较少表达IFN-γ(3/13),而8例EOC患者的实体瘤标本表达IL-2(4/8)、TGF-β​​2(4/8)和IL-10(5/8)的转录本,但不表达IFN-γ(0/8);(iii)CD4+ TCRαβ+ T细胞系表达IFN-γ(4/4)、IL-2(4/4)和IL-10(3/4)的转录本,而CD8+ TCRαβ+ T细胞系表达IFN-γ(5/5)、IL-2(1/5)和IL-10(2/5)的转录本。这些T细胞系均未表达TGF-β​​2转录本。实体瘤中IL-2和TGF-β​​2转录本的频率显著低于PEC中的频率(P = 0.0475)。表达IFN-γ​​、IL-2和IL-10转录本CD4+或CD8+ T细胞系,是在含有rIL-2的培养物中,从TIL标本衍生而来,这些标本在不存在rIL-2的情况下不一定表达这些细胞因子。与PEC中相同转录本相比,T细胞系中细胞因子转录本的频率,IFN-γ更高(P = 0.0005),TGF-β​​2更低(P = 0.0001)。观察到体内或TIL衍生细胞系中细胞因子转录本的表达,与通过细胞因子产生或体外细胞毒性所表现出的功能之间存在关联。

相似文献

9
Expression of cytokine mRNA transcripts in renal cell carcinoma.
Immunol Cell Biol. 1998 Aug;76(4):357-62. doi: 10.1046/j.1440-1711.1998.00759.x.

引用本文的文献

2
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis.
Cancers (Basel). 2015 Sep 29;7(4):1994-2011. doi: 10.3390/cancers7040872.
3
Tumor infiltrating lymphocytes in ovarian cancer.
Cancer Biol Ther. 2015;16(6):807-20. doi: 10.1080/15384047.2015.1040960. Epub 2015 Apr 20.
5
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
Front Immunol. 2011 Jul 21;2:29. doi: 10.3389/fimmu.2011.00029. eCollection 2011.
6
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.
Genes Dev. 2010 Feb 1;24(3):241-55. doi: 10.1101/gad.1874010. Epub 2010 Jan 15.
7
Immunological profiling of a panel of human ovarian cancer cell lines.
Cancer Immunol Immunother. 2008 Jan;57(1):31-42. doi: 10.1007/s00262-007-0347-7. Epub 2007 Jun 20.
9
Ovarian cancer, the coagulation pathway, and inflammation.
J Transl Med. 2005 Jun 21;3:25. doi: 10.1186/1479-5876-3-25.
10
Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC).
J Transl Med. 2004 Jun 25;2(1):23. doi: 10.1186/1479-5876-2-23.

本文引用的文献

7
Negative regulation of cell growth by TGF beta.
Biochim Biophys Acta. 1996 Mar 18;1242(3):185-99. doi: 10.1016/0304-419x(95)00009-5.
9
Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Cancer. 1993 Oct 15;72(8):2433-40. doi: 10.1002/1097-0142(19931015)72:8<2433::aid-cncr2820720822>3.0.co;2-l.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验